Search for: "Taylor v. Attorney General of the State of Delaware et al"
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
2 Dec 2017, 10:13 am
The Delaware Department of Health and Social Services et al., C.A. [read post]
26 Dec 2013, 1:27 pm
The issue was recently considered by the Delaware Chancery court in Great Hill Equity Partners IV, LP v. [read post]
31 Dec 2018, 4:07 pm
Pitfalls of Consumer Collection Suit Defense in Texas: Taylor v. [read post]
6 Oct 2017, 11:39 pm
Those pages are often not attached to the archived Signature Page, but the program lender’s home state can generally be inferred from the identity of the lender as shown both on the Signature Page and on the Note Disclosure Statement. [read post]
11 Nov 2018, 4:03 pm
Its attorneys—hired by TSI on a state-by-state basis--never do that. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
14 Mar 2016, 2:56 am
Utilizing a different rationale, the court in Avon State Bank v. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
